Could a simple change in insulin timing improve pregnancy outcomes for women with diabetes?
NCT ID NCT07224893
First seen Nov 05, 2025 · Last updated Jun 23, 2026 · Updated 28 times
Summary
This study compares taking insulin glargine once a day versus twice a day in pregnant women with pregestational diabetes (type 2 diabetes that existed before pregnancy). About 200 participants will be randomly assigned to one of the two groups, and their blood sugar levels will be tracked continuously. The goal is to see if twice-daily dosing leads to better blood sugar control and fewer pregnancy complications like preterm birth or high blood pressure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sentara Norfolk General Hospital, Norfolk, Virginia 23507
RECRUITINGNorfolk, Virginia, 23507, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
insulin glargine
What this could lead to
If successful, this could show that a simple change in dosing schedule helps pregnant women with diabetes achieve better blood sugar control, potentially reducing pregnancy complications.
What could go wrong
This is a small, early-phase study (200 participants) comparing two common dosing schedules, so the difference may be small or not clinically meaningful. Results may not apply to all types of diabetes or pregnancies.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.